Compare Enact Holdings Inc (ACT) vs Herbalife Nutrition Ltd (HLF) Price & Performance

ACT trades at $49.54, up 2.14% today, near the consensus price target of $49.00. The stock shows strong profitability with a net income margin of 54.51% and a P/E ratio of 10.36, indicating potential undervaluation. Recent Q2 2026 earnings beat estimates at $1.26 per share. Technical indicators signal a bullish trend, though RSI levels suggest overbought conditions. The company maintains stable dividends, with a $0.24 payout scheduled for September 2026.

Outlook is cautiously optimistic with solid fundamentals and analyst support, but risks include reliance on steady earnings growth and market volatility. The stock offers value with room for upside if earnings momentum continues, though overbought technicals may prompt short-term consolidation.

HLF trades at $11.71, up 1.65% on the day, with a bearish technical signal from moving averages. The company shows mixed earnings, missing Q2 2026 EPS estimates but achieving four consecutive quarters of sales growth. Valuation ratios appear attractive with a P/E of 7.53 and P/S of 0.24, though negative shareholder equity and high debt levels present financial risks. Recent news includes a planned CFO transition and inclusion in TIME's America's Best Companies 2026 list.

The outlook for HLF balances low valuation against operational and financial challenges. Investment opportunity lies in potential margin improvement and debt reduction, but risks include earnings volatility, high leverage, and competitive pressures in the nutrition space. Analyst sentiment is cautiously optimistic with a majority buy rating.